AnalystsKumaraguru Raja
Kumaraguru Raja's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4985 out of 5014 analysts
Average Return
-54.32%
Win Rate
4%1 out of 23
Risk vs Reward
Poor
Good

Kumaraguru Raja's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Veru IncVERU
+29.07%$22.70$29.30
2019-07-30 -
2020-07-30
Strong Buy

Kumaraguru Raja Analyst Color

Get additional color on Kumaraguru Raja's coverage of popular stocks

Kumaraguru Raja's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Intensity Therapeutics IncINTS
1Strong Buy$3.00+1,193.10%Upgrades
a month ago
Palisade Bio IncPALI
2Strong Buy$16.00+2,575.59%Maintains
4 months ago
Quince Therapeutics IncQNCX
1Strong Buy$9.00+462.50%Initiates Coverage On
9 months ago
Sab Biotherapeutics IncSABS
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
Forte Biosciences IncFBRX
2Strong Buy$100.00N/AInitiates Coverage On
a year ago
Adial Pharmaceuticals IncADIL
2Strong Buy$150.00N/AReiterates
2 years ago
Genenta Science SpaGNTA
1Strong Buy$15.00N/AAssumes
2 years ago
Atyr Pharma IncATYR
1Strong Buy$9.00N/AReinstates
3 years ago
Rain Oncology IncRAIN2
1Strong Buy$21.00N/AReinstates
3 years ago
Apexigen IncAPGN
1Strong Buy$15.00N/AReinstates
3 years ago
Monopar TherapeuticsMNPR
2Strong Buy$90.00N/AReinstates
3 years ago
Veru IncVERU
2Strong Buy$310.00N/AMaintains
3 years ago
Dermata Therapeutics IncDRMA
1Strong Buy$33,600.00N/AInitiates Coverage On
4 years ago
Oncternal Therapeutics IncONCT
1Strong Buy$320.00N/AInitiates Coverage On
4 years ago
9 Meters Biopharma IncNMTRQ
1Strong Buy$120.00N/AAssumes
4 years ago
Nls Pharmaceutics LtdNLSP
1Strong Buy$480.00N/AInitiates Coverage On
5 years ago
Lisata Therapeutics IncLSTA
1Strong Buy$10.00N/AMaintains
5 years ago
Cns Pharmaceuticals IncCNSP
1Strong Buy$9,000,000.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.